安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Soleno Therapeutics – Development and commercialization of novel . . .
Soleno is committed to maximizing shareholder value by developing and commercializing innovative therapeutic products with the goal of improving the lives of individuals living with complex, life-threatening rare diseases with unmet medical needs
- Products - Soleno
TripleFlo is the triple-wall pipe offered exclusively by Soleno Rigid pipe with smooth interior and exterior walls for drainage applications Composed of three interconnected layers of HDPE, it is designed to offer an exceptional level of rigidity
- Connecting you to the future of water management - Soleno USA
Soleno Strengthens Position as Leader in Water Management Press Release Grand Opening in New York : New Facility in Saratoga Springs News Use of KustomFlo pipes for the rehabilitation of the storm sewer on Saint-Pierre Street South in Joliette Case Study
- First Developer of Solutions for Mastering Water Sustainably - Soleno
Soleno is your partner for the agriculture of tomorrow By delivering innovative water management solutions, we can optimize water usage and quality for better biodiversity, soil sustainability and crop efficiency
- FDA Approval for its Drug Lifted Soleno Therapeutics (SLNO) Shares by . . .
Soleno Therapeutics, Inc (NASDAQ:SLNO) is a clinical-stage biopharmaceutical company The one-month return of Soleno Therapeutics, Inc (NASDAQ:SLNO) was 4 02%, and its shares gained 99 55% of
- Soleno Therapeutics Announces Multiple Presentations at the . . . - BioSpace
Soleno is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases The company’s first commercial product, VYKAT™ XR (diazoxide choline) extended-release tablets, formerly known as DCCR, is a once-daily oral treatment for hyperphagia in adults and children 4 years of age and older with
- About Us - Soleno USA
Soleno has become a leader in the design, manufacture and distribution of sustainable thermoplastic products for water management By acquiring the world-renowned Krah technology, SOLENO USA, our american division, can now provide the most robust and tailor-made piping systems, KUSTOMFLO
- Soleno Therapeutics: Overbought On VYKAT Approval Enthusiasm
Soleno's latest 10-K reports that it had cash burn as reflected by net cash used in operating activities for 2024 of ~$69 million Its cash burn for Q1, 2025 was ~$33 million
|
|
|